Related Experiment Video
Updated: Jul 2, 2025

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
569
Artificial Intelligence in Kidney Disease: A Comprehensive Study and Directions for Future Research
Chieh-Chen Wu1, Md Mohaimenul Islam2, Tahmina Nasrin Poly3
1Department of Healthcare Information and Management, School of Health and Medical Engineering, Ming Chuan University, Taipei 111, Taiwan.
Diagnostics (Basel, Switzerland)
|February 24, 2024
Summary
Artificial intelligence (AI) applications in kidney disease research are rapidly growing. This bibliometric analysis reveals key trends, leading publishers, and top contributing countries and institutions in this dynamic field.
Area of Science:
- Medical Informatics
- Nephrology
- Artificial Intelligence
Background:
- Artificial intelligence (AI) is increasingly applied in healthcare, particularly in kidney disease research.
- Understanding the growth, trends, and collaborations in AI for kidney disease is crucial for future research directions.
Purpose of the Study:
- To systematically analyze and quantify scientific output, research trends, and collaborative networks in AI applications for kidney disease.
- To identify leading journals, institutions, and countries contributing to AI in nephrology research.
Main Methods:
- Bibliometric analysis of AI-related articles published in the Web of Science from 2012 to November 20, 2023.
- Descriptive analysis of publication growth rates by authors, journals, institutions, and countries.
- Network visualization of country collaborations and author keywords to identify research hotspots and trends.
Main Results:
- A significant exponential growth trend in annual publications on AI in kidney disease was observed.
- Nephrology Dialysis Transplantation, American Journal of Transplantation, and Scientific Reports were leading journals.
- The United States, China, and India were the top contributing countries, with Mayo Clinic, Harvard University, and Sun Yat-Sen University as leading institutions.
Conclusions:
- The field of AI in kidney disease is dynamic and rapidly progressing, characterized by exponential growth.
- The analysis provides valuable insights into emerging patterns, technological shifts, and interdisciplinary collaborations.
- Findings aid in recognizing key players and trends to advance knowledge in AI-driven nephrology.

